Trial intelligence / Profile preview

Bioequivalence study of generic leflunomide 20 mg vs Arava 20 mg in healthy Thai male volunteers under fasting

TCTR20260317002Phase 1Not yet recruiting

Sponsor
International Bio Service
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of leflunomide (2 arms), sponsored by International Bio Service. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

leflunomide

Beyond the preview

Go deeper on TCTR20260317002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260317002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call